STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate UpdateGlobeNewsWire • 05/15/24
STRATA Skin Sciences Surpasses 100 Domestic Installations of TheraClear®X Devices as of March 31, 2024GlobeNewsWire • 05/14/24
STRATA Skin Sciences to Participate in the Benchmark Healthcare House Call Virtual 1x1 Investor ConferenceGlobeNewsWire • 05/13/24
STRATA Skin Sciences to Report First Quarter 2024 Financial Results on May 15, 2024 and Provide Corporate UpdateGlobeNewsWire • 05/08/24
STRATA Skin Sciences Announces XTRAC® Comeback Placements in the First Quarter of 2024GlobeNewsWire • 04/30/24
STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and JapanGlobeNewsWire • 04/09/24
STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024GlobeNewsWire • 03/13/24
STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap FinancialGlobeNewsWire • 02/26/24
STRATA Skin Sciences Announces Expansion of Distribution Agreement with Kosmo MeditechGlobeNewsWire • 12/29/23
STRATA Skin Sciences to Participate in the Benchmark 12th Annual Discovery One-on-One Investor ConferenceGlobeNewsWire • 12/01/23
STRATA Skin Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023GlobeNewsWire • 11/02/23
STRATA Skin Sciences, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 10/31/23